tci Part B Insider - 2008 Issue 17
PART B COVERAGE UPDATE: Medicare Won't Cover DNA Stool Tests to Screen for Cancer--Stick to FOBT Instead
CMS notes that the currently available DNA stool test still requires FDA reviewIf your physician is one of the many who supports using screening DNA stool tests to detect the early signs of colorectal cancer, expect disappointment about a new CMS ruling.On April 28, CMS issued a coverage decision memorandum outlining its stance on these new tests. Although CMS acknowledged that selected physicians and associations had declared the DNA test a promising and cost-effective alternative to more invasive testing, the agency's decision came down to the fact that the only commercially available test currently on the market still...
To read the full article, sign in and subscribe to tci Part B Insider.
Thank you for choosing Find-A-Code, please Sign In to remove ads.